| Fund ID | 805-5277043567 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | No |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 100% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| Gmo Quality Investment Fund | Hedge | $4.82B |
| Gmo Equity Dislocation Fund, L.P. | Hedge | $3.28B |
| Gmo Amplified Equity Dislocation Solution Fund, L.P. | Hedge | $1.59B |
Gmo Sgm Major Markets Investment Fund reports $1.2 million in gross assets, among the top 94% of private funds by size.
The stated minimum investment is $5 million.
Gmo Sgm Major Markets Investment Fund is managed by Grantham Mayo van Otterloo & Co LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.